Pipex Pharmaceuticals' Oral TRIMESTA Initiates Dosing in Phase II ...
Market Wire (press release) - USA
TRIMESTA (oral estriol) has completed an initial 22-month, single-agent, crossover Phase II clinical trial in the US for the treatment of MS in relapsing ...
See all stories on this topic

Utah families encouraged by stem cell treatments
Daily Herald - Provo,UT,USA
Tim said he saw many patients at the Beike Clinic who experienced dramatic improvements in conditions such as multiple sclerosis and ataxia. ...
See all stories on this topic

Pipex Pharmaceuticals' Oral TRIMESTA Initiates Dosing in Phase II ...
CNNMoney.com - USA
Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic ...
See all stories on this topic

A Promising Pipeline At Pipex
BusinessWeek - USA
One is a further oral formulation called Trimesta, for women with multiple sclerosis. It has completed Phase I/II trials, funded by a $5 million grant from ...
See all stories on this topic